Qiagen NV | QIA - Betriebsaufwand

Aktienkurs
34.95
Täglich Wechseln
-0.40 -1.13%
Monatlich
2.06%
Jährlich
-5.28%
Q2 Prognose
34.58




Betriebsaufwand Veränderung Datum
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
argenx SE USD 914.57M 137.58M 2025-12
Avita Medical AUD 28.02M 1.55M 2025-12
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Moderna USD 1.54B 259M 2025-12
Organon & Co USD 906M 362M 2025-09
Qiagen NV USD 418.54M 23.25M 2025-12
Revvity USD 626.22M 25.62M 2025-12
Tectonic Therapeutic USD 21.52M 374K 2025-12
Viatris USD 3.86B 335.7M 2025-12
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12